Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Procter and Gamble
With
ARYx Therapeutics
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Were diagnosed with PDS at least 6 months prior to screening, OR had onset of 2 or more PDS symptoms at least 6 months prior to screening.
Experienced early satiety or bothersome postprandial fullness repeatedly during the 3 months prior to screening.
Had a normal upper GI endoscopy within the past year.
You may not be if
Heartburn that occurs \>3 times per week
Current Helicobacter pylori (H pylori) infection confirmed by stool sample testing or breath testing, or H pylori eradication therapy within the 6 months prior to screening
Any alarm symptoms including uninvestigated anemia, rectal bleeding, weight loss, or unresolved fever within the 6 months prior to screening
At screening, a QT interval corrected for heart rate using Bazett's correction formula (QTcB) \>440 msec as determined by the Investigator.
Clareo Health | A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome
